Clinical trial · Interventional
Hypnosis: a Path to Appeasement
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Cancer | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| anxiety questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Anxiety scores
- interventionNames
- Other: anxiety questionnaire
Primary outcomes (1)
- measure
- Evolution of anxiety
- timeFrame
- Week 6 after 2 hypnosis sessions
- description
- Difference in anxiety measured before starting hypnotherapy care and after 2 hypnosis sessions. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Secondary outcomes (7)
- measure
- Evolution of anxiety before hypnotherapy and after 3 months of follow-up in hypnotherapy
- timeFrame
- Month 3 after 3 hypnosis sessions
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients over 18 years old, fluent in French. * Patients starting hypnotherapy for anxiety disorders. * Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21 * Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease. * Diagnosis announcement less than 2 months old Exclusion Criteria: * Persons deprived of their liberty by a judicial or administrative decision * Adults subject to a legal protection measure
References
Publications (0)
Data not yet available